Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Perpetua Medical

5.26 SEK

+0.38 %

Less than 1K followers

PERP B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.38 %
+17.15 %
+5.41 %
+18.20 %
+22.90 %
+3.14 %
-90.09 %
-94.57 %
-97.41 %

Perpetua Medical is a serial acquirer of profitable companies in the healthcare sector. The company's operations are conducted according to a decentralized ownership model, where operations and decision-making take place in independent subsidiaries. The name Perpetua (Latin for 'eternal') reflects the strategy of acquiring and long-term ownership of companies without any fixed time horizon. Until 2023, the company had a different business focus and was called Pharmacolog. The head office is in Uppsala.

Read more
Market cap
23.78M SEK
Turnover
605.5 SEK
Revenue
6.94M
EBIT %
-35.45 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19.12
2025

Extraordinary general meeting '25

20.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release6/18/2024, 8:15 PM

Perpetua Medical AB: Perpetua Medical has entered a letter of intent regarding the acquisition of a majority stake in ES-Medical AB

Perpetua Medical
Regulatory press release6/14/2024, 11:15 AM

Perpetua Medical AB: Resolutions from the Annual General Meeting 2024 in Pepetua Medcial

Perpetua Medical
Regulatory press release6/12/2024, 6:30 AM

Perpetua Medical AB: Perpetua Medical is offered a loan facility of up to SEK 25 million

Perpetua Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/17/2024, 6:30 AM

Perpetua Medical AB: Perpetua Medical publishes interim report January - March 2024

Perpetua Medical
Regulatory press release5/15/2024, 7:30 AM

Perpetua Medical AB: NOTICE OF ANNUAL GENERAL MEETING IN PERPETUA MEDICAL AB (PUBL)

Perpetua Medical
Regulatory press release4/24/2024, 6:30 AM

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO

Perpetua Medical
Press release4/23/2024, 6:30 AM

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name

Perpetua Medical
Regulatory press release4/17/2024, 6:30 AM

Nolsterby Invest AB has increased its holding further in Pharmacolog

Perpetua Medical
Regulatory press release4/16/2024, 2:42 PM

Pharmacolog: ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024

Perpetua Medical
Regulatory press release4/16/2024, 1:07 PM

Pharmacolog publishes annual report for 2023

Perpetua Medical
Regulatory press release4/8/2024, 6:30 AM

Nolsterby Invest AB has increased its holding in Pharmacolog

Perpetua Medical
Regulatory press release4/4/2024, 6:30 AM

Pharmacolog announces the appointment of Anders Hedlund as interim CEO

Perpetua Medical
Regulatory press release3/14/2024, 9:20 AM

Pharmacolog: NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)

Perpetua Medical
Regulatory press release3/14/2024, 9:15 AM

Pharmacolog provides update on new business direction and proposes name change

Perpetua Medical
Regulatory press release3/1/2024, 11:55 AM

Pharmacolog announces upcoming change in management

Perpetua Medical
Regulatory press release2/27/2024, 10:38 AM

Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million

Perpetua Medical
Regulatory press release2/20/2024, 1:10 PM

Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million

Perpetua Medical
Regulatory press release2/20/2024, 7:30 AM

The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024

Perpetua Medical
Regulatory press release2/16/2024, 7:30 AM

Year-end bulletin Pharmacolog 2023

Perpetua Medical
Regulatory press release2/15/2024, 7:30 AM

Pharmacolog investigates the possibilities for a new business direction

Perpetua Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.